Tango Therapeutics (TNGX) EBT (2020 - 2025)
Historic EBT for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $15.9 million.
- Tango Therapeutics' EBT rose 15452.55% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.4 million, marking a year-over-year increase of 1849.35%. This contributed to the annual value of -$130.1 million for FY2024, which is 2803.27% down from last year.
- As of Q3 2025, Tango Therapeutics' EBT stood at $15.9 million, which was up 15452.55% from -$38.8 million recorded in Q2 2025.
- Tango Therapeutics' 5-year EBT high stood at $15.9 million for Q3 2025, and its period low was -$39.8 million during Q1 2025.
- Moreover, its 5-year median value for EBT was -$25.5 million (2024), whereas its average is -$24.2 million.
- In the last 5 years, Tango Therapeutics' EBT tumbled by 95625593.22% in 2021 and then soared by 15452.55% in 2025.
- Quarter analysis of 5 years shows Tango Therapeutics' EBT stood at -$21.9 million in 2021, then crashed by 32.65% to -$29.0 million in 2022, then dropped by 5.88% to -$30.7 million in 2023, then dropped by 22.48% to -$37.6 million in 2024, then surged by 142.19% to $15.9 million in 2025.
- Its EBT stands at $15.9 million for Q3 2025, versus -$38.8 million for Q2 2025 and -$39.8 million for Q1 2025.